Literature DB >> 10197814

Influence of apolipoprotein E genotype on neuronal damage and apoE immunoreactivity in human hippocampus following global ischemia.

K Horsburgh1, D I Graham, J Stewart, J A Nicoll.   

Abstract

Apolipoprotein E (apoE) influences the response to and outcome from brain injury possibly through alterations in neuronal repair mechanisms. This study aimed to determine alterations in neuronal and glial apoE after brain injury in patients and sought to determine whether possession of an apoE-epsilon4 allele influences the degree of apoE immunoreactivity or the degree of neuronal damage following brain injury. ApoE immunoreactivity and neuronal damage were semiquantitatively assessed in the temporal lobe of a group of controls (n = 44) and in a group of patients who had an episode of global ischemia and subsequently died (n = 58, survival ranged from 1 hour to 3 months). There was a significant degree of neuronal damage in all hippocampal sectors and in the neocortex of the global ischemia group compared with controls (p < 0.0001). Glial apoE immunoreactivity was significantly increased in hippocampal sectors (CA1, CA2, CA3/CA4, dentate fascia) in the global ischemia group compared with controls (p < 0.01). Neuronal apoE immunoreactivity was significantly increased in all hippocampal sectors (CA1, CA2, CA3/CA4, dentate fascia) and in the neocortex of the global ischemia group compared with controls (p < 0.0001). There was a significant and positive association between the degree of neuronal apoE immunoreactivity and the degree of neuronal damage in the global ischemia cases (r2 = 0.691, p < 0.001) and there was not an association in the control group. Possession of an apoE-epsilon4 allele did not influence the degree of neuronal or glial apoE immunoreactivity or the degree of neuronal damage in the global ischemia cases or the controls. The data indicate apoE is markedly increased in neurons and glia following brain injury. In this study, apoE genotype did not appear to influence neuronal damage, glial apoE or intraneuronal apoE following injury

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10197814     DOI: 10.1097/00005072-199903000-00002

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  7 in total

1.  The distribution of apolipoprotein E alleles in Scottish perinatal deaths.

Authors:  J-C Becher; J W Keeling; N McIntosh; B Wyatt; J Bell
Journal:  J Med Genet       Date:  2005-09-23       Impact factor: 6.318

Review 2.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease.

Authors:  Robert W Mahley; Karl H Weisgraber; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

3.  Apolipoprotein E epsilon4 allele and outcomes of traumatic spinal cord injury.

Authors:  Amitabh Jha; Daniel P Lammertse; Joseph R Coll; Susan Charlifue; Christopher T Coughlin; Gale G Whiteneck; Gordon Worley
Journal:  J Spinal Cord Med       Date:  2008       Impact factor: 1.985

4.  Endocytic pathway alterations in human hippocampus after global ischemia and the influence of APOE genotype.

Authors:  Barry W McColl; David I Graham; Christopher J Weir; Fiona White; Karen Horsburgh
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

Review 5.  Relationship between Apolipoprotein Superfamily and Parkinson's Disease.

Authors:  Lin Li; Ming-Su Liu; Guang-Qin Li; Jie Tang; Yan Liao; Yang Zheng; Tong-Li Guo; Xin Kang; Mao-Ting Yuan
Journal:  Chin Med J (Engl)       Date:  2017-11-05       Impact factor: 2.628

6.  α-synuclein-lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson's disease patients.

Authors:  Wojciech Paslawski; Justyna Zareba-Paslawska; Xiaoqun Zhang; Katharina Hölzl; Henrik Wadensten; Mohammadreza Shariatgorji; Shorena Janelidze; Oskar Hansson; Lars Forsgren; Per E Andrén; Per Svenningsson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-03       Impact factor: 11.205

Review 7.  APOE2: protective mechanism and therapeutic implications for Alzheimer's disease.

Authors:  Zonghua Li; Francis Shue; Na Zhao; Mitsuru Shinohara; Guojun Bu
Journal:  Mol Neurodegener       Date:  2020-11-04       Impact factor: 18.879

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.